Stockscreener 앱 받기
18.84
1.60%
0.68
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19 - Insider Monkey
Amphastar Earnings Call Balances Growth and Margin Strain - TipRanks
Has Amphastar Pharmaceuticals Bottomed Out After Its Steep Decline - Kavout
8 Best Small Cap Pharma Stocks to Buy Right Now - Insider Monkey
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today - Yahoo Finance
Amphastar forecasts BAQSIMI revenue flat to up low single digits, with 3% list price increase - MSN
Amphastar Pharmaceuticals Q1 2026: Revenue Miss and Pricing Pressures on BAQSIMI - IndexBox
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call - Yahoo Finance
Pharma Earnings Season 2026: Amphastar Flat, Eli Lilly Surges in Q1News and Statistics - IndexBox
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment - Yahoo Finance
There May Be Some Bright Spots In Amphastar Pharmaceuticals' (NASDAQ:AMPH) Earnings - simplywall.st
Amphastar Pharmaceuticals' (NASDAQ:AMPH) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19 - Moomoo
Is Amphastar Pharmaceuticals Inc (AMPH) a Bargain After 5.6% Dro - GuruFocus
Amphastar Shares Fall After Wells Fargo Downgrade - Moomoo
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Amphastar Pharmaceuticals tackles BAQSIMI discount pressure, keeps sales outlook - MSN
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook - MarketBeat
AMPH: Proprietary and biosimilar pipeline expansion drives growth, anchored by BAQSIMI® and Primatene MIST - TradingView
How The Amphastar Pharmaceuticals (AMPH) Narrative Is Shifting As Targets Fall And New Drugs Launch - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Neutral Rating from Piper Sandler - MarketBeat
(AMPH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Amphastar price target lowered to $21 from $25 at Piper Sandler - TipRanks
Earnings Miss: Amphastar Pharmaceuticals, Inc. Missed EPS By 75% And Analysts Are Revising Their Forecasts - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue - Sahm
Needham downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Quarterly Earnings Results - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2026 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals, Inc. $AMPH Shares Purchased by Denali Advisors LLC - MarketBeat
Amphastar Pharmaceuticals (AMPH) Is Up 9.4% After Profit Falls Despite New Drug Launches And Licensing Deals - Yahoo Finance
Amphastar Pharmaceuticals Q1 2026 10-Q: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart
Amphastar Balances Margin Pain With Pipeline Gains - TipRanks
Amphastar Q1 2026 Results: Revenue Growth Fueled by New Launches | May 2026News and Statistics - IndexBox
Amphastar Pharmaceuticals, Inc.Common Stock (Nasdaq:AMPH) Stock Quote - FinancialContent
Amphastar reports Q1 EPS 42c, consensus 71c - TipRanks
Amphastar cut to Hold at Needham after ‘disappointing’ results - TipRanks
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownWhat's Next? - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
12 Health Care Stocks Moving In Friday's Intraday SessionAIM ImmunoTech (AMEX:AIM), Akanda (NASDAQ:AKA - Benzinga
Why Amphastar Pharmaceuticals (AMPH) Is Up 9.4% After Profit Squeeze Despite Flat Q1 2026 Sales - simplywall.st
Earnings call transcript: Amphastar’s Q1 2026 earnings miss expectations By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Amphastar (AMPH) Q1 2026 Earnings Transcript - The Globe and Mail
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Amphastar Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 Results Miss Estimates, Stock Slides After Hours - ChartMill
Profit falls as costs rise at Amphastar (NASDAQ: AMPH) in Q1 2026 - Stock Titan
Amphastar: Q1 Earnings Snapshot - Barchart.com
Amphastar held sales at $171M, but profit fell on higher costs - Stock Titan
Earnings slide at Amphastar (NASDAQ: AMPH) despite steady Q1 revenue - Stock Titan
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 - Corsicana Daily Sun
MSN Money - MSN
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference - Black Hills Pioneer
1.38%
1.89%
자본화:
|
볼륨(24시간):